Komori
Takara Bio (4974) · PolicyRestatedLatest Business Plan (2026-05-13): "Reframed"

Oversight and Auditing by Outside Officers and the Audit & Supervisory Board

First written in FY2016. 1 of 4 entries say "Advanced", first in FY2019. Latest entry: 2026-05-13.

4entries
11years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2016AdvancedFY2019RestatedFY20242016: 120162017: 020172018: 020182019: 120192020: 020202021: 020212022: 020222023: 020232024: 120242025: 020252026: 1
Same theme, other companies
Oversight structure involving outside directors and independent officersA theme 511 companies write about · 0 as a headwind · 520 as a tailwind

The whole theme swung hardest in 2023: 14 of 103 companies on the "Worse" side.

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 197 companies compared. The sentences above are computed from all 197.Comparing 200 of the theme's 520 threads.
Moved together

"CDMO Business Centered on the Gene and Cell Processing Center" moved the same way as this thread, in the same document, in 2 of its 4 moves.

2★1
  1. ★This thread
  2. 1CDMO Business Centered on the Gene and Cell Processing Center2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Takara Bio yet. It last moved in the Business Plan of 2026-05-13: "Reframed".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Oversight and Auditing by Outside Officers and the Audit & Supervisory Board | TAKARA BIO INC. (4974) | Komori